Showing results (181-190 of 653) with videos related to

Sort By:
Pageof 66
Cancer|October 15, 2010
Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomyMin Yi, Steven J Kronowitz, Funda Meric-Bernstam, et al.
Annals of Surgical Oncology|May 31, 2020
COVID-19 Pandemic and Surgical Oncology: Preserving the Academic MissionTimothy M Pawlik, Douglas S Tyler, Baran Sumer, et al.
Annals of Surgical Oncology|July 11, 2021
Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic TherapyLeisha C Elmore, Henry M Kuerer, Carlos H Barcenas, et al.
Cancer|April 30, 2008
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapyJacqueline S Jeruss, Lisa A Newman, Gregory D Ayers, et al.
Journal of Immunotherapy and Precision Oncology|January 16, 2025
Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B TrialMohamed A Gouda, Abdulrazzak Zarifa, Yali Yang, et al.
Oncotarget|November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patientsReva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.
Cancer|May 7, 2008
How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?Min Yi, Funda Meric-Bernstam, Merrick I Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experienceBanu Arun, Soley Bayraktar, Diane D Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
cMET and phospho-cMET protein levels in breast cancers and survival outcomesKanwal P Raghav, Wenting Wang, Shuying Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancerSao Jiralerspong, Shana L Palla, Sharon H Giordano, et al.
Pageof 66